HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Traditional Chinese Medicine

698.091

-3.502-0.50%

Number of Gainers:3

Number of Losers:7

Number of Flat:1

PE:- -

High:702.419

Open:699.462

Low:691.057

Close:701.593

Loading ...

JBM (Healthcare) Unit Buys 90% Stake in Medicine Maker

MT Newswires Live

Tong Ren Tang's 2024 Profit Declines 12%

MT Newswires Live

Luye Pharma Group Rivastigmine Patch Approved for Alzheimer's Treatment in Japan

MT Newswires Live

Asian Market's Top Value Stock Picks For April 2025

Simply Wall St.

PuraPharm Corp FY Gross Margin 53.7%

THOMSON REUTERS

Luye Pharma - Rivastigmine Twice Weekly Transdermal Patch- Approved for Marketing in Japan

THOMSON REUTERS

Tong Ren Tang Technologies Co Ltd - FY Revenue RMB7.26 Bln

THOMSON REUTERS

Tong Ren Tang Technologies FY EPS RMB 0.41

THOMSON REUTERS

Shineway Pharmaceutical's 2024 Profit Slides 13%; Shares Fall 8%

MT Newswires Live

BRIEF-China Shineway Pharmaceutical Group FY Net Income RMB 840 Million

China Shineway Pharmaceutical - to Declare First Interim Dividend for 2025 of RMB36 Cents per Share

THOMSON REUTERS

Modern Chinese Medicine Group FY Revenue RMB 214.1 Million

THOMSON REUTERS

Consun Pharmaceutical Group Posts 16% Increase in 2024 Profit

MT Newswires Live

Baiyunshan Pharma's Subsidiary Gets Nod to Trial Yupingfeng Tea Bag as Treatment For Hypothyroidism

MT Newswires Live

BRIEF-Consun Pharmaceutical Group FY Profit Attributable RMB910.5 Million

Consun Pharmaceutical - FY Profit Attributable RMB910.5 Mln

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1606/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","market":"HK","secType":"PLATE","nameCN":"Traditional Chinese Medicine","latestPrice":698.091,"timestamp":1743667694978,"preClose":701.5931,"halted":0,"volume":102577200,"delay":0,"changeRate":-0.004992,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-3.502075,"latestTime":"04-03 16:00:00","open":699.4615,"high":702.419,"low":691.05676,"amount":235532486,"amplitude":0.016195,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1743989400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1743643800000,1743652800000],[1743656400000,1743667200000]],"pbRate":0.891874,"peRate":13.604986,"turnoverRate":0.006819,"increases":4,"decrements":7,"flats":0,"marketCap":76994960272,"floatMarketCap":49275664016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","high":702.419,"amplitude":0.016195,"preClose":701.5931,"low":691.05676,"pbRate":"0.891874","latestPrice":698.091,"volume":102577200,"delay":0,"open":699.4615,"prevYearClose":739.0471,"prevWeekClose":718.463,"prevMonthClose":689.055,"prevQuarterClose":689.055,"fiveDayClose":728.182,"twentyDayClose":700.747,"sixtyDayClose":700.896,"secType":"PLATE","market":"HK","turnoverRate":0.006819,"peRate":13.604986,"marketCap":76994960272,"floatMarketCap":49275664016,"timestamp":1743667694978,"nameCN":"Traditional Chinese Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1606\",,,,undefined,":{"bkCode":"BK1606","up":3,"down":7,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1606\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524253726","title":"JBM (Healthcare) Unit Buys 90% Stake in Medicine Maker","url":"https://stock-news.laohu8.com/highlight/detail?id=2524253726","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524253726?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:44","pubTimestamp":1743680662,"startTime":"0","endTime":"0","summary":"JBM   unit Arrow King completed the acquisition of a 90% equity stake in Tin Hee Tong Medicine Factory for HK$171 million, a Thursday filing with the Hong Kong bourse said.The parties had entered into the purchase agreement in February.Tin Hee Tong Medicine Factory engages mainly in the manufacture, marketing, and sales of proprietary Chinese medicine Tin Hee Tong Tin Hee Pills.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK4137","02161","HCSG","MKR.USD.CC","MKR.USD.HKCC","BK1606"],"gpt_icon":0},{"id":"2524165780","title":"Tong Ren Tang's 2024 Profit Declines 12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524165780","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524165780?lang=en_us&edition=fundamental","pubTime":"2025-04-01 16:49","pubTimestamp":1743497392,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Technologies'  attributable profit fell 12% to 521.8 million yuan in 2024 from 590.2 million yuan in 2023, according to a Friday filing with the Hong Kong bourse.Earnings per share at the traditional Chinese medicine company decreased to 0.41 yuan from 0.46 yuan in the previous year.Revenue grew 7.2% to 7.26 billion yuan from 6.77 billion yuan a year earlier.The company declared a final dividend of 0.18 yuan per share, similar to last year's dividend. The dividend will be paid on Aug. 11.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01666","BK1583","BK1515","BK1606","BK1191"],"gpt_icon":0},{"id":"2524156338","title":"Luye Pharma Group Rivastigmine Patch Approved for Alzheimer's Treatment in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2524156338","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524156338?lang=en_us&edition=fundamental","pubTime":"2025-04-01 15:01","pubTimestamp":1743490909,"startTime":"0","endTime":"0","summary":"Luye Pharma Group (HKG:2186) received approval from Japan's Ministry of Health, Labour and Welfare for its Rivastigmine twice weekly transdermal patch, according to a Monday filing with the Hong Kong ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1606","BK1191","02186","BK1583"],"gpt_icon":0},{"id":"2524195750","title":"Asian Market's Top Value Stock Picks For April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524195750","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524195750?lang=en_us&edition=fundamental","pubTime":"2025-04-01 12:07","pubTimestamp":1743480462,"startTime":"0","endTime":"0","summary":"As global markets grapple with economic uncertainty and inflation concerns, the Asian stock markets have shown resilience, presenting opportunities for value investors. In this environment, identifying undervalued stocks becomes crucial as they may offer potential for growth amidst cautious optimism and market volatility.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/sg/diversified-financials/sgx-aiy/ifast-shares/news/asian-markets-top-value-stock-picks-for-april-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01681","BK6503","BK1191","BK6052","AIY.SI","BK1606"],"gpt_icon":0},{"id":"2523910640","title":"PuraPharm Corp FY Gross Margin 53.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2523910640","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523910640?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:20","pubTimestamp":1743420006,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nPLX64F5ED:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1606","01498","BK1191"],"gpt_icon":0},{"id":"2523914154","title":"Luye Pharma -  Rivastigmine Twice Weekly Transdermal Patch- Approved for Marketing in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2523914154","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523914154?lang=en_us&edition=fundamental","pubTime":"2025-03-31 18:47","pubTimestamp":1743418029,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QC02N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1606","02186","BK1583","BK1191"],"gpt_icon":0},{"id":"2522837574","title":"Tong Ren Tang Technologies Co Ltd - FY Revenue RMB7.26 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2522837574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522837574?lang=en_us&edition=fundamental","pubTime":"2025-03-28 21:02","pubTimestamp":1743166949,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nPLXF7CA22:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1583","BK1191","BK1606","01666"],"gpt_icon":0},{"id":"2522571027","title":"Tong Ren Tang Technologies FY EPS RMB 0.41","url":"https://stock-news.laohu8.com/highlight/detail?id=2522571027","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522571027?lang=en_us&edition=fundamental","pubTime":"2025-03-28 21:02","pubTimestamp":1743166949,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nPLXF7CA22:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1606","01666","BK1191","BK1583"],"gpt_icon":0},{"id":"2522510190","title":"Shineway Pharmaceutical's 2024 Profit Slides 13%; Shares Fall 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2522510190","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522510190?lang=en_us&edition=fundamental","pubTime":"2025-03-28 16:04","pubTimestamp":1743149040,"startTime":"0","endTime":"0","summary":"China Shineway Pharmaceutical's  attributable profit fell 13% to 840.1 million yuan in 2024 from 969.5 million yuan in 2023, according to a Friday filing with the Hong Kong bourse.Earnings per share at the traditional Chinese medicine manufacturer fell to 1.11 yuan from 1.28 yuan in the previous year.Revenue declined 16% to 3.78 billion yuan from 4.52 billion yuan a year earlier.The company declared its first interim dividend of 0.36 yuan per share, payable May 20 to shareholders on record as of May 7.Shares plunged 8% during Friday's afternoon trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK1606","02877"],"gpt_icon":0},{"id":"2522595043","title":"BRIEF-China Shineway Pharmaceutical Group FY Net Income RMB 840 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522595043","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522595043?lang=en_us&edition=fundamental","pubTime":"2025-03-28 12:07","pubTimestamp":1743134840,"startTime":"0","endTime":"0","summary":"BRIEF-China Shineway Pharmaceutical Group FY Net Income RMB 840 MillionMarch 28  - China Shineway Pharmaceutical Group Ltd 2877.HK:GROUP FY NET INCOME RMB 840 MILLIONGROUP FY GROSS MARGIN 75%GROUP FY SALES RMB 3,780 MILLIONTO DECLARE FIRST INTERIM DIVIDEND FOR 2025 OF RMB36 CENTS PER SHAREFurther company coverage: 2877.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nPLXCD46D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02877","BK1191","BK1606"],"gpt_icon":0},{"id":"2522100595","title":"China Shineway Pharmaceutical - to Declare First Interim Dividend for 2025 of RMB36 Cents per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2522100595","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522100595?lang=en_us&edition=fundamental","pubTime":"2025-03-28 12:01","pubTimestamp":1743134484,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nPLXCD46D3:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1606","02877","BK1191"],"gpt_icon":0},{"id":"2522280069","title":"Modern Chinese Medicine Group FY Revenue RMB 214.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522280069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522280069?lang=en_us&edition=fundamental","pubTime":"2025-03-26 22:20","pubTimestamp":1742998803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nPLX229D5A:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1606","01643"],"gpt_icon":0},{"id":"2522814415","title":"Consun Pharmaceutical Group Posts 16% Increase in 2024 Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2522814415","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522814415?lang=en_us&edition=fundamental","pubTime":"2025-03-26 16:02","pubTimestamp":1742976136,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group  reported a 16.1% increase in profit attributable to equity shareholders for 2024 to 910.5 million yuan from 784.5 million yuan a year earlier, according to a Wednesday filing with the Hong Kong bourse.Earnings per share were 1.09 yuan, an 11.2% increase from 0.98 yuan the previous year.Revenue increased by 14.6% to 2.97 billion yuan from 2.59 billion yuan in the prior year.The board recommended a final dividend of HK$0.30 per share.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01681","BK1606","BK1191"],"gpt_icon":0},{"id":"2522689817","title":"Baiyunshan Pharma's Subsidiary Gets Nod to Trial Yupingfeng Tea Bag as Treatment For Hypothyroidism","url":"https://stock-news.laohu8.com/highlight/detail?id=2522689817","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522689817?lang=en_us&edition=fundamental","pubTime":"2025-03-26 12:27","pubTimestamp":1742963222,"startTime":"0","endTime":"0","summary":"Guangzhou Baiyunshan Pharmaceutical's  subsidiary, Guangzhou Baiyunshan Chen Li Ji Pharmaceutical Factory, received the Chinese drug administration's approval to conduct clinical trials on the Yupingfeng tea bag, according to a Shanghai Stock Exchange filing on Wednesday.The product will be tested as a treatment for Hashimoto's thyroiditis, subclinical hypothyroidism and clinical hypothyroidism patients who exhibit symptoms of spleen and lung Qi deficiency after LT4 treatment, the pharmaceutical company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00874","BK1521","BK0096","BK0175","BK1515","BK0183","BK0097","BK0012","BK0070","BK0196","BK0239","BK1191","BK0028","BK1606","BK0188","600332","BK1197"],"gpt_icon":0},{"id":"2522289886","title":"BRIEF-Consun Pharmaceutical Group FY Profit Attributable RMB910.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522289886","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522289886?lang=en_us&edition=fundamental","pubTime":"2025-03-26 12:19","pubTimestamp":1742962756,"startTime":"0","endTime":"0","summary":"BRIEF-Consun Pharmaceutical Group FY Profit Attributable RMB910.5 MillionMarch 26  - Consun Pharmaceutical Group Ltd 1681.HK:FY GROSS MARGIN 75.6%FY REVENUE RMB 2,970 MILLIONFINAL DIVIDEND OF HKD0.3 PER SHAREFY PROFIT ATTRIBUTABLE RMB910.5 MILLIONFurther company coverage: 1681.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nPLX6BC862:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681","BK1191","BK1606"],"gpt_icon":0},{"id":"2522786048","title":"Consun Pharmaceutical - FY Profit Attributable RMB910.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2522786048","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522786048?lang=en_us&edition=fundamental","pubTime":"2025-03-26 12:10","pubTimestamp":1742962254,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nPLX6BC862:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01681","BK1606","BK1191"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16}]}}